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Prosthetic joint infection (PJI) is an increasingly important health concern in theWestern world due to the rising number of
joint arthroplasties. Althoughmost infections are considered to be monomicrobial, the introduction of sonication procedures
has led to an increase in the detection of polymicrobial infections. To date, no published studies have investigated the presence
of different clones of the same species in the infected patient. The objective of this study was to analyze whether the phenomenon
of polyclonality, or the appearance of different clones in the same sample, occurs in PJI. Bacteria isolated by sonication of the
retrieved implant from patients with theoretically monomicrobial PJI were included in the study. Two techniques (random am-
plified polymorphic DNA [RAPD] andmatrix-assisted laser desorption ionization–time of flight [MALDI-TOF] mass spectrom-
etry) were used to determine the presence of several clones in the same sample. Results were analyzed to determine bacterial spe-
cies and infection type (acute versus chronic). RAPD showed a predominance of polyclonal cases (16 of 19). However, when
performing the analysis withMALDI-TOF, all cases were shown to be polyclonal. We were unable to establish any relationship
between the twomethodologies. Polyclonality is a common phenomenon in acute and chronic PJI. Further studies are needed to
establish the potential implications of this phenomenon on patient outcomes.
Prosthetic joint replacement, or arthroplasty, is a surgical pro-cedure that has improved the quality of life for many people
around the world, providing pain relief and improved function-
ality to limbs (1–3). However, 10% of all patients who undergo
this operation develop complications at some point in their lives;
although it is not the most common, infection is one of the most
significant of these complications, having an incidence of 1% to
3% (1, 3, 4). The microorganisms that cause most cases of pros-
thetic joint infection (PJI) are those belonging to the genus
Staphylococcus (60% of cases), of which infections caused by Staph-
ylococcus aureus constitute 25%. Gram-negative organisms (En-
terobacteriaceae, Pseudomonas aeruginosa, and other species) rep-
resent a smaller proportion of cases (10%) (1, 2, 5). Notably, up to
20% to 25% of PJIs are polymicrobial infections (1–3).
When the growth conditions of the bacteria causing PJI be-
come hostile, as may occur during antibiotic therapy, a coping
mechanism known as spontaneous random hypermutation oc-
curs as the bacteria attempt to overcome the unfavorable environ-
ment (6). This results in the development of polyclonality or the
appearance of different clones in the same sample or environment
(6). Polyclonality can also occur when the patient is infected with
different clones from the same section of skin, which may occur
either during surgery or afterwards and is likely a more common
phenomenon (7). Several reports have found polyclonality in mo-
nomicrobial infections among isolates of small-colony variant
staphylococci, which present phenotypically different colonies
(8–10), but this phenomenon may also happen among phenotyp-
ically identical colonies.
The main objective of this study was to determine whether
polyclonality can be detected in bacterial isolates from patients
with apparently monomicrobial PJI. In addition, we aimed to
compare the results obtained using the matrix-assisted laser de-
sorption ionization–time of flight (MALDI-TOF) mass spectrom-
etry technique with those obtained from random amplified poly-
morphic DNA (RAPD).
MATERIALS AND METHODS
Isolates from 19 consecutive PJIs were included in the study. We selected
those consecutive species from samples obtained from PJIs diagnosed
from December 2011 to December 2013 that belonged to patients who
fulfilled the following criteria.
Patients were diagnosed as having PJI according to internationally
established criteria (11). Clinical patient data were analyzed and classified
as acute, delayed/chronic, or hematogenous PJI according to the afore-
mentioned criteria (11). Of these patients, only those with sonicated im-
plants that had colony counts of 10,000 CFU/ml and had positive cul-
tures from other periprosthetic samples according to the criteria
described by Atkins et al. (12) were selected for the study. Only apparently
monomicrobial infections were included. All joint prostheses were soni-
cated using a previously described protocol (13, 14). Twenty colonies
from the same species were subcultured and frozen at80°C until further
experiments were performed. Although in most cases colonies were ap-
parently identical to each other, one of the infections presented colonies
with different morphologies (small-colony variants S. aureus strain).
Therefore, colonies were randomly selected, except in this case, where
morphologically different colonies were chosen.
Antimicrobial susceptibility testing of all isolates was performed by a
disc-plate assay according to CLSI (15) procedures using a turbidimeter
(DensiChek Plus; bioMérieux, Marcy l’Etoile, France) to achieve a 0.5
McFarland standard turbidity. A difference between isolates was consid-
ered for a difference in the inhibition zone diameter of5 mm. The tested
antibiotics were penicillin, cefoxitin, gentamicin, levofloxacin, vancomy-
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cin, co-trimoxazole, and erythromycin for gram-positve bacteria; ampi-
cillin, amoxicillin-clavulanic acid, cefuroxime, ceftriaxone, ceftazidime,
imipenem, meropenem, ertapenem, levofloxacin, co-trimoxazole, fosfo-
mycin, gentamicin, and amikacin for Enterobacteriaceae; and piperacillin-
tazobactam, ceftazidime, cefepime, aztreonam, imipenem, meropenem,
doripenem, colistin, co-trimoxazole, doxiciline, gentamicin, amikacin,
norfloxacin, and ciprofloxacin for nonfermenter Gram-negative rods (all
discs from bioMérieux, Marcy l’Etoile, France). Major differences were
considered when a change in the interpretation (i.e., from susceptible to
resistant) was detected.
Clinical charts of the patients were retrospectively reviewed in order to
obtain clinically relevant data using a predefined protocol. The criteria
used for the evaluation were those defined by the Infectious Diseases So-
ciety of America (IDSA) (11). The study was approved by the Ethics in
Research Committee of our institution (reference number EO 04/
2015_FJD).
MALDI-TOF. One loop from a pure culture was placed on a specific
carrier and was then mixed with a suitable matrix (1 l of -cyano-4-
hydroxycinnamic acid [CHCA Vitek-MS; bioMérieux, Marcy l’Etoile,
France]). After drying the mixture at room temperature, the slides were
inserted into a mass spectrometer (MS) (Vitek 3.2.0 to 5; bioMérieux,
Marcy l’Etoile, France). The software (Vitek acquisition station MS) pro-
cessed the registered signal, resulting in a spectrum of intensity versus
mass in daltons (Da).
RAPD. Bacteria were inoculated onto Trypticase soy 5% sheep blood
agar (bioMérieux, Marcy l’Etoile, France) for 24 h at an atmosphere of 5%
CO2 and a temperature of 37°C. The purity of each culture was checked,
and then all of the biomass from each agar plate was suspended in 500 l
of sterile distilled water. Then, samples were heated to 95°C in a thermo-
block (FB15101 dry bath; Fisher Scientific, Madrid, Spain) for 30 min.
Samples were then centrifuged for 5 min at 14,000 rpm, and 450 l of
supernatant was retained. S. aureusDNA was extracted using the easyMag
2.0 automated DNA extractor (bioMérieux, Marcy l’Etoile, France).
Subsequently, DNA was quantified with the NanoDrop ND-1000
spectrophotometer (Thermo Scientific, Madrid, Spain), and the samples
were then adjusted to a final concentration of 100 ng/l DNA.
Primers used for RAPD analysis were selected from the literature (Ta-
ble 1). Three different primers were used for each bacterial species. For
microorganisms belonging to the genus Staphylococcus, common primers
were used for all species.
In order to perform the amplification, a master mixture containing 19
l of DNA-free water and 1 l of primer was added to PuReTaq Ready-
To-Go PCR beads (GE Healthcare, Madrid, Spain) along with 5 l of the
sample DNA. This was subjected to a program consisting of 39 cycles at
94°C for 1 min, 36°C for 1 min, and 72°C for 2 min. After completing all
cycles, a final period of 10 min at 72°C was performed. For the genetic
material extracted from staphylococci, the amplification program was ini-
tially 5 min at 94°C followed by 39 cycles of 93°C for 1 min, 37°C for 30 s,
and 72°C for 1 min. This program concluded with 8 min at 72°C.
Electrophoresis was performed in a 3% agarose gel (Agarose Basic;
AppliChem GmbH, Germany) to which 5 l of ethidium bromide was
added. To prepare the gel and to immerse it in the electrophoresis tank,
1 Tris-borate-EDTA (TBE) buffer was used. Twenty microliters of the
mixture was loaded into the wells of the gel and run for 4 to 5 h at 80 V.
Gels were analyzed under UV transillumination, and the images were
captured for further analysis.
Data analysis. The spectra obtained from the mass spectrometer
(MALDI-TOF technique) and the images of the agarose gels (RAPD tech-
nique) were analyzed using BioGene software (BioGene, Kimbolton
Cambs, United Kingdom), which considered strains with a homology of
95% to 100% as being identical. The identities of the profiles with 3 sets of
primers were used as the criteria for monoclonality using RAPD.
Data were statistically analyzed using the EPI-INFO 3.5.4 (2012) soft-
ware (CDC, Atlanta, GA, USA). To compare qualitative variables, Fisher’s
exact test was used.
RESULTS
During the study period, 86 culture-positive PJI were diagnosed
(39 acute, 7 hematogenous, and 40 chronic/delayed). Among
these, only 19 fulfill all of the established criteria to be included in
the study. The bacterial species included wereEnterobacter cloacae,
Pseudomonas aeruginosa, Klebsiella pneumoniae, Sphingomonas
paucimobilis, S. aureus, Staphylococcus epidermidis, and Staphylo-
coccus lugdunensis (Table 2). Clinical characteristics of the patients
and results of the microbiological studies appear in Table 3.
The RAPD assays of the 2 cases of E. cloacae revealed poly-
clonality in both, with detection of 7 different clones in each of the
cases. In contrast, all clones of P. aeruginosa were identical in the 2
cases studied. As in the case of E. cloacae, RAPD analysis of K.
pneumoniae showed the existence of 7 individual clones. Another
example of polyclonality was found in the analysis of S. paucimo-
bilis, with 9 different clones. Regarding analyses of S. aureus, the
TABLE 1 Name and sequence of the primers used in this study
Species Primer Sequence (5= to 3=) Reference
Enterobacter cloacae ECLC-1 GGTGCGGGAA Clementino et al. (43)
ECLC-2 GTTTCGCTCC
ECLC-3 GTAGACCCGT
Pseudomonas aeruginosa PSAE-1 ACGGCCGACC Mahenthiralingan et al. (44)
PSAE-2 GCTGGGCCGA
PSAE-3 GCCCGAGCGG
Klebsiella pneumoniae F-4 GGTATCAGG Brisse and Verhoef, (45) Ashayeri-Panah et al. (46)
AP-4 TCACGATGCA
A-10 GTGATCGCAT
Sphingomonas paucimobilis OPA-5 AGGGGTCTTG Perola et al., (47)
OPB-10 CTGCTGGAC
M-13 TTATGTAAAACGACGGCCAGT Hsueh et al., (48)
Staphylococcus aureus OLP-6 GAGGGAAGAG Reinoso et al., (49)
Staphylococcus epidermidis OLP-11 ACGATGAGCC
Staphylococcus lugdunensis OLP-13 ACCGCCTGCT
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results were highly variable, ranging from monoclonal infections
(1 case) to cases in which there were 2, 4, 5, 7, 8, 10, 11, and even 12
different clones. Analysis of S. epidermidis showed less variability
than that of S. aureus, resulting in a maximum of 3 different clones
(2 of the cases). The only case of S. lugdunensis had 4 different
clones.
Based on the results obtained by RAPD, there was a clear pre-
dominance of polyclonal infections (16 of the 19 cases studied).
The causal organisms of monoclonal infections were S. aureus (1
case) and P. aeruginosa (2 cases). Conversely, the analysis per-
formed with MALDI-TOF suggested that all infections were poly-
clonal, including the cases that were considered to be monoclonal
by RAPD. Figures 1 and 2 illustrate examples of the spectra ob-
tained by MALDI and the corresponding dendrogram for one case
of E. cloacae. Examples of the dendrograms obtained from RAPD
images are shown in Fig. 3.
Regarding clinical data, we compared acute infections (10
cases) versus chronic/delayed infections (9 cases). Fisher’s exact
test revealed no significant differences when the presence of poly-
clonality between acute and chronic/delayed prosthetic infections
was compared. Likewise, although no significant differences were
found when comparing S. aureus and S. epidermidis, the sample
was too small to get a reliable conclusion from those data.
DISCUSSION
Although the etiology of prosthetic infection is diverse, several
studies have shown that the most frequently isolated microorgan-
isms are staphylococci (1–3). S. aureus is a commonly described
microorganism in different hospital-acquired infections (16),
probably because of its abundance on the skin, as in the case of S.
epidermidis (17). Several authors have concluded that the patho-
genicity of these microorganisms in implant-related infections lies
in their ability to form biofilms (2, 18, 19), as these structures
protect the bacteria from the immune system and also make them
less susceptible to antibiotics (2, 7, 19–22). We must also not for-
get other species of staphylococci, such as S. lugdunensis, which is
being increasingly recognized as the cause of severe infections (2,
23). The emergence of these organisms may be related to the pres-
ence of a gene complex with a similar order and sequence in all of
the 3 aforementioned species (20). Other species studied in this
work, such as P. aeruginosa, E. cloacae, S. paucimobilis, and K.
pneumoniae, have also been reported to cause PJI, although less
frequently than staphylococci (2, 24, 25).
The use of low-intensity ultrasound in the infected prosthesis
releases the biofilm without destroying the microorganisms,
thereby improving the sensitivity of conventional cultures (2, 3,
21, 22). Our study aimed to determine whether several clones of
microorganisms can be found in apparently monomicrobial in-
fections. Our hypothesis rests on the “race for the surface” theory
(19, 26, 27), as we think that several clones of the same bacteria can
contaminate the prosthesis during the surgery and that we may
only identify these bacteria through molecular techniques.
Our results support the role of RAPD typing as a useful tool for
the detection of genomic polymorphisms (28). In fact, there have
been studies of the strain differentiation of S. aureus based on this
technique (16, 29). Our results show that 1 case of S. aureus infec-
tion was monoclonal but that 8 cases were polyclonal, with a vary-
ing number of clones between them. According to Byun et al., (16)
the combination of several primers increases the ability to dis-
criminate between strains. Ueta et al. (17) reported the detection
of different genetic profiles of S. epidermidis isolated from the
conjunctival sac of the same subject. Although the reproducibility
of this technique is problematic (30), this problem can be mini-
mized if all strains are processed simultaneously in the same gel, as
we have done in our study. Moreover, the use of restrictive criteria
to establish monoclonality increases the likelihood that our results
closely resemble those obtained with other techniques. In addi-
tion, this technique is easy to perform for laboratories with no
access to more reliable techniques, such as pulsed-field gel electro-
phoresis (PFGE) or complete DNA sequencing, which require the
use of more specialized installations.
Nowadays, MALDI-TOF is one of the most highly valued
methodologies in bacterial identification (3, 31–33). Unlike
RAPD, it is based on the analysis of bacterial proteins. This is
probably the main cause of the absence of monoclonal cases in our
study. Protein synthesis can be quite variable from one organism
to another since this process is affected by factors such as the
availability of mRNA (pretranslational level) or reading effective-
ness (translational level). There are also numerous inhibitors of
the process of protein biosynthesis, which act by blocking events
in the initiation and elongation stages. All of this increases the
possibility of detecting differences between strains of the same
microorganism.
Although MALDI-TOF mass spectrometry can be used as a
reliable technique in the bacterial identification at the species level
(34), it is not yet clear whether this method makes it possible to
differentiate at the strain level (33). Some authors have stated that
the discriminatory power of MALDI-TOF to distinguish different
clones of S. aureus and Enterococcus faecium is insufficient com-
pared with that of a molecular technique such as multilocus se-
quence typing (MLST) (34). According to these authors, it is
highly unlikely that a single marker peak (the difference between 2
strains) has sufficient discriminatory power to allow the forma-
tion of clusters and may be unreliable for the identification of
clonal lineages (34). These authors support their claim by explain-
ing that MALDI-TOF only detects a bacterial subproteome in a
limited range of masses and that only a selected number of pro-
teins are ionized, which reduces the number of signals available
for strain characterization. Another report supports the ability of
MALDI-TOF for subtyping (35). In the study, 158 isolates of
staphylococci were characterized by MALDI-TOF using specific
software, ensuring 100% accuracy at the genus and species levels
and thus showing a great potential for discrimination between
strains. In fact, this methodology has been used to differentiate
between strains of E. coli (36, 37). This approach and particularly
the dendrogram analysis may be improved if common spectral
peaks or biomarkers are omitted (38).
In our study, the results of MALDI-TOF analysis show clear
TABLE 2 Number and percentage of infections caused by each
organism isolated for the total number of cases studied (19 cases)
Bacterial species No. of infections Percentage of infections
Enterobacter cloacae 2 10.52
Pseudomonas aeruginosa 2 10.52
Klebsiella pneumonia 1 5.26
Sphingomonas paucimobilis 1 5.26
Staphylococcus aureus 9 47.37
Staphylococcus epidermidis 3 15.79
Staphylococcus lugdunensis 1 5.26
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identification at the genus and species levels but do not allow for a
common approach to be established to discriminate between
strains, although the resulting dendrograms reveal clear differ-
ences in the clones studied. Again, the small number of cases stud-
ied and the lack of specific software to establish the clonality of
isolates are important limitation of this study. Therefore, it is nec-
essary to conduct more studies with this technique using a greater
number of cases in order to homogenize the criteria for identifi-
cation and identity between strains compared with those of other
widely accepted molecular techniques.
The main limitation of our report is our selection of tech-
niques. RAPD has been claimed as a technique with low reproduc-
ibility, but we have the experience that, if strict conditions and
criteria are followed, the obtained results can be considered useful
for discrimination purposes (39–41). This technique also has the
advantage of being easy to perform without complex equipment,
FIG 1 Example of spectra and dendrogram corresponding to case 5 (E. cloacae). BioGene software analyzes the spectra and considers the strains with a 95% to
100% homology to be identical. The dendrogram groups these strains with the same spectrum.
FIG 2 Example of spectra and dendrogram corresponding to case 5 (E. cloacae). BioGene software analyzes the spectra and considers the strains with a 95% to
100% homology to be identical. The dendrogram groups these strains with the same spectrum.
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such as that needed for other reference techniques like PFGE or
complete-genome sequencing, so it can be performed in medium-
size laboratories like ours. Regarding the MALDI-TOF methodol-
ogy, as recently reviewed (42), this technique lacks the proper
definition of criteria for the interpretation of the results, and this
limitation must be considered carefully in this research. Because
of these limitations, further studies are needed to confirm or deny
the results obtained by our study.
In conclusion, the RAPD technique revealed 16 cases of poly-
clonality among 19 cases of monomicrobial PJI. The MALDI-TOF
methodology showed an even higher percentage, with all cases
being polyclonal. When performing statistical analysis, no signif-
icant differences in the appearance of polyclonality were found
when comparing acute and chronic prosthetic infections. No cor-
respondence was detected between the two techniques. Further
studies are needed to confirm these results and to establish the
actual role of this phenomenon in patient outcomes.
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